Serina Therapeutics SER
NYSE SER
$1.51 +0.08 (+5.59%)
As of: Nov 11, 2026 · 3:59 PM EST

Serina Therapeutics (SER) Capital Leases (2019 - 2023)

Updated

Serina Therapeutics (SER) recorded Capital Leases of $1,000 in Q4 2023.

Analysis

Serina Therapeutics (SER) Capital Leases (2019 - 2023) Analysis & Trends

  • The Q4 2023 figure is the highest quarterly Capital Leases since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Serina Therapeutics 23.59 Mn -35.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1,000.00
Sep 30, 2019 417,000.00
Jun 30, 2019 221,000.00
API Access

Serina Therapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=SER&period=max&api_key=YOUR_API_KEY